Cellectar Biosciences, Inc. (CLRB) Operating cash flow 2016–2025
Cellectar Biosciences, Inc. (CLRB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$23.1MFY2025 · since FY2016: -$8.3M → -$23.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$23.1M | +51.4% |
| FY2024 | -$47.6M | -47.0% |
| FY2023 | -$32.4M | -28.4% |
| FY2022 | -$25.2M | -11.8% |
| FY2021 | -$22.6M | -62.0% |
| FY2020 | -$13.9M | -19.1% |
| FY2019 | -$11.7M | -2.2% |
| FY2018 | -$11.4M | -3.8% |
| FY2017 | -$11.0M | -33.1% |
| FY2016 | -$8.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CLRB financial trends
CLRB RevenueCLRB Net incomeCLRB Net marginCLRB Gross profitCLRB Gross marginCLRB Operating incomeCLRB Operating marginCLRB Free cash flowCLRB Capital expendituresCLRB Return on equityCLRB Stock buybacksCLRB Dividends paidCLRB Total assetsCLRB Total liabilitiesCLRB Shareholders’ equityCLRB overview →